Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Evaluation of Stomach Neoplasms With 3-Dimensional Computed Tomography: Focus on the Potential Role of Cinematic Rendering

Rowe, Steven P., MD, PhD; Chu, Linda C., MD; Fishman, Elliot K., MD

Journal of Computer Assisted Tomography: September/October 2018 - Volume 42 - Issue 5 - p 661–666
doi: 10.1097/RCT.0000000000000761
Abdominal Imaging

Evaluation of stomach neoplasms by traditional 3-dimensional (3D) computed tomography methods such as volume rendering and maximum-intensity projection plays an important role in lesion detection and characterization, preoperative planning, staging, and follow-up. Recently, a new 3D visualization method has become available known as cinematic rendering (CR). This novel technique makes use of a complex global lighting model to impart photorealistic levels of detail to 3D images. Although this new technique has yet to be systematically studied for the evaluation of stomach neoplasms, its intrinsic ability to create realistic shadowing effects to enhance understanding of the 3D relative locations of anatomic structures and to enhance detail and texture may prove valuable for a variety of applications. In this article, we demonstrate the CR appearance of multiple different gastric neoplasms, describe potential advantages of CR, and suggest future research directions.

From The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD.

Received for publication April 6, 2018; accepted April 9, 2018.

Correspondence to: Steven P. Rowe, MD, PhD, The Russell H. Morgan Department of Radiology and Radiological Science, The James Buchanan Brady Urological Institute, and Department of Urology, Johns Hopkins University School of Medicine, 601 N. Caroline St, Baltimore, MD 21287 (e-mail: srowe8@jhmi.edu).

No funding was received by the authors in relation to writing this work.

E.K.F. receives research support from Siemens and GE Healthcare and is a cofounder and stockholder in HipGraphics, Inc. The other authors have no relevant conflicts of interest to report.

No patient data are included in this article, and informed consent was not applicable.

This article does not detail a defined study, and no ethical approval was necessary.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.